Síndrome de DRESS inducido por sulfasalazina. ¿Consideramos esta reacción adversa grave al indicar el fármaco? Caso Clínico

Autores/as

  • Edith Pérez de Arce Hospital Clínico Universidad de Chile
  • Rodrigo Quera Clinica Las Condes
  • Lilian Flores Clinica Las Condes
  • Rodrigo Blamey Clinica Las Condes

Palabras clave:

Colitis, Ulcerative, Drug Hypersensitivity, Sulfasalazine

Resumen

DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is a severe, rare and potentially lethal idiosyncratic condition associated with the use of some drugs. Given its broad spectrum of presentation, clinical suspicion is essential for management, since it requires the immediate withdrawal of the culprit drug, support measures and the use of corticosteroids as the first line of treatment. We report a 24-year-old woman with a diagnosis of ulcerative colitis with joint involvement despite the use of infliximab, who presented symptoms, signs and laboratory compatible with DRESS syndrome on the third week after indicating sulfasalazine for her baseline disease.

Descargas

Publicado

2020-09-10

Cómo citar

Pérez de Arce, E., Quera, R., Flores, L., & Blamey, R. (2020). Síndrome de DRESS inducido por sulfasalazina. ¿Consideramos esta reacción adversa grave al indicar el fármaco? Caso Clínico. Revista Médica De Chile, 148(8). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/8121

Número

Sección

Reporte de Caso Clínico

Artículos más leídos del mismo autor/a

1 2 3 4 > >>